Advanced search
Publication Cover
Hematology Volume 17, 2012 - Issue 1
Submit an article Journal homepage
501
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infection

Y M TatfengDepartment of Medical Laboratory ScienceFaculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Bayelsa State, Nigeria,Correspondence[email protected]
,
D E AgbonlahorDepartment of Medical Laboratory ScienceFaculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Bayelsa State, Nigeria,
&
O F AmegorDepartment of Medical Laboratory ScienceCollege of Health Sciences, Igbinedion University, Okada, Nigeria
Pages 47-50 | Published online: 12 Nov 2013

References

  • Graham RS. Mortality from sickle cell disease in Africa. BMJ 2005;330:432–3.
  • Martin TW, Weisman IM, Zeballos RJ, Stephenson SR. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait. Am J Med 1989;87:48–56.
  • Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al.. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002;359:1311–2.
  • Chippaux JP, Massougbodji A, Castel J, Akogbeto M, Zohoun I, Zohoun T. Plasmodium falciparum or P. malariae parasitemia in carriers of sickle cell trait in various Benin biotypes. Rev Epidemiol Sante Publique 1992;40:246–51.
  • Roberts DJ, Williams TN. Haemoglobinopathies and resistance to malaria. Redox Rep 2003;8:304–10.
  • Yuthavong Y, Bunyaratvej A, Kamchonwongpaisan S. Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. Blood Cells 1990;16:591–7.
  • West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell disease. J Clin Epidemiol 1992;45:893–909.
  • Wun T, Cordoba M, Rangaswami A, Cheung AW, Paglieroni T. Activated monocytes and platelet monocyte aggregates in patients with sickle cell disease. Clin Lab Haematol 2002;24:81–8.
  • Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, et al.. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:83–9.
  • Francis RB, Haywood LJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 1992;84:611–5.
  • Malave I, Perdomo Y, Escalona E, Rodriguez E, Anchustegui M, Malave H, et al.. Level of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease. Acta Haematol 1993;90:172–6.
  • Michaels LA, Ohene-Frempong K, Zhao H, Douglas SD. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood 1998;92:3148–51.
  • Kuvibidila S, Gardner R, Ode D, Yu L, Lane G, Warrier RP. Tumor necrosis factor alpha in children with sickle cell disease in stable condition. J Natl Med Assoc 1997;89:609–15.
  • Taylor SC, Shacks SJ, Qu Z. In vivo production of type 1 cytokines in healthy sickle cell disease patients. J Natl Med Assoc 1999;91:619–24.
  • Taylor SC, Shacks SJ, Villicana SM, Olivares J, Dinkins GA. Interferon production in sickle cell disease. Lymphokine Res 1990;9:415–23.
  • Cheesbrough M. Medical laboratory manual for tropical countries. Vol. II, 2nd ed. Low priced EL/BS edition. Oxford: Tropical Health Technology; 1992. p. 221–45.
  • Dacie JV, Lewis SM. Basic haematological techniques. In: , Lewis M, Bain B J, Bates I. editors. Practical haematology. 9th ed. London: Churchill Livingstone; 2001, p. 19–46.
  • Baron EJ, Peterson LR, Finegold FS. Immunodiagnosis. In: , James F S, Potts L M, Chris M, Julie T, editors. Bailey and Scott diagnostic microbiology. 9th ed. St Louis, MO: Mosby; 1994. p. 134–45.
  • Penman B, Gupta S. Evolution of virulence in malaria. J Biol 2008;7:22.
  • Long GH, Chan BH, Allen JE, Read AF, Graham AL. Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evol Biol 2008;9:725–32.
  • Friedman MJ. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci 1978;75:1994–7.
  • Angulo I, Manuel F. Cytokines in the pathogenesis of and protection against malaria. Clin Diag Lab Immun 2002;9:1145–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.